Rivista di Psichiatria, published by PENSIERO SCIENTIFICO EDITORE, stands as a significant contributor to the field of Psychiatry and Mental Health since its inception in 1975. With an ISSN of 0035-6484 and an E-ISSN of 2038-2502, this esteemed journal offers a platform for rigorous academic discourse and cutting-edge research, helping to shape contemporary psychiatric practices and theories. Currently holding a Q2 designation in Psychiatry and Mental Health based on the 2023 category quartiles, and ranking #197 out of 567 in Scopus, it reflects a commendable 65th percentile among its peers. The journal welcomes contributions that encompass a broad range of topics related to mental health, encouraging contributions from a multidisciplinary approach, which aids in its goal of advancing the understanding and application of psychiatric science. While it is a traditional journal without Open Access options, access to its valuable content can support researchers, clinicians, and students in their pursuit of knowledge and innovation within the field. Situated in Rome, Italy, at VIA SAN GIOVANNI VALDARNO 8, ROME 00138, the journal continues to enhance its rich legacy, promoting the exchange of ideas and fostering collaboration amongst practitioners and scholars alike.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.

Psychiatry and Behavioral Sciences is an esteemed journal dedicated to advancing the understanding of mental health and behavioral disorders. Published by YERKURE TANITIM & YAYINCILIK HIZMETLERI A S, this journal provides a platform for groundbreaking research and scholarly articles in the field of psychiatry, psychology, and related disciplines. With an E-ISSN of 2636-834X, Psychiatry and Behavioral Sciences aims to disseminate knowledge that contributes to the effectiveness of treatments, the development of novel therapeutic practices, and the promotion of mental well-being. Although currently not an Open Access journal, it retains a commitment to reaching a wide audience through institutional subscriptions and partnerships. Scholars, practitioners, and students alike will find valuable insights and evidence-based research within its pages, making it an essential resource for anyone involved in the study or practice of mental health.

The International Journal of Methods in Psychiatric Research, published by Wiley, stands as a vital resource within the field of Psychiatry and Mental Health. Since its inception in 1996, this journal has been dedicated to advancing the methodologies employed in psychiatric research, making a significant scholarly contribution that resonates within the academic community. With an impact factor reflective of its prestigious standing and a Q2 ranking in the 2023 Scopus category for Psychiatry and Mental Health, the journal garners attention for its rigorous peer-reviewed articles. It transitioned to Open Access in 2020, enhancing accessibility for a global audience of researchers, professionals, and students who seek to stay abreast of the latest advances and innovative methodologies in psychiatric research. The convergence of research discourse from 1996 to 2024 showcases its enduring relevance and commitment to the challenges and developments that shape mental health practices today. Situated in the United States at 111 River St, Hoboken, NJ, this journal is poised to continue facilitating critical discussions and promoting excellence in psychiatric research.

PSYCHIATRISCHE PRAXIS, an esteemed journal published by GEORG THIEME VERLAG KG, serves as a vital resource in the field of psychiatry and mental health. Established in 1974, this German journal offers a compelling mix of original research, clinical insights, and theoretical discussions, contributing to the advancement of knowledge up to its historical convergence slated for 2024. With a distinguished Scopus ranking of #250 out of 567 in the Psychiatry and Mental Health category, and a 2023 Category Quartile of Q3, it stands as a significant platform for researchers and professionals. The journal does not currently offer Open Access options; however, its reputation and impact within the community place it as a valuable asset for those dedicated to understanding and improving mental health practices. PSYCHIATRISCHE PRAXIS engages its readership with innovative studies and authoritative viewpoints, making it an essential tool for scholars, practitioners, and students aiming to enrich their insight into psychiatric care and research.

British Journal of Psychiatry, published by Cambridge University Press, stands as a pivotal resource in the realm of mental health and psychiatry. With an impressive impact reflected in its Q1 classifications in both Medicine (miscellaneous) and Psychiatry and Mental Health, this esteemed journal ranks 23rd out of 567 in its field according to Scopus, achieving an exceptional 96th percentile. Since its inception in 1963, the journal has continued to push the boundaries of research and discourse, serving as a platform for groundbreaking studies that enhance our understanding of psychiatric conditions and promote effective therapeutic strategies. Though it does not operate with an open-access model, the British Journal of Psychiatry remains an essential publication for researchers, clinicians, and students alike, offering in-depth insights and innovative findings that are crucial for navigating the complexities of mental health.

Current Psychiatry Research and Reviews is an innovative open access journal dedicated to the dynamic field of psychiatry and mental health. Published by Bentham Science Publishers Ltd, this journal provides a platform for researchers and practitioners to disseminate pivotal findings, reviews, and advancements in psychiatric research. While the journal currently holds a Q4 status in the Psychiatry and Mental Health category, it seeks to elevate standards with interdisciplinary contributions aimed at improving patient outcomes and treatment methodologies. With a publication window spanning from 2019 to 2024, the journal aims to enhance global discussions in mental health sciences, encouraging submissions that explore evidence-based practices, innovative therapeutic techniques, and the epidemiology of mental health disorders. The journal's address in the Netherlands positions it strategically within Europe’s vibrant research community, making it an essential resource for researchers, professionals, and students alike who are invested in the evolution of psychiatric science.

Archives of Psychiatry and Psychotherapy is a distinguished journal published by the Polish Society of Psychiatry, focusing on the dynamic fields of clinical psychology and psychiatry. Established in 2001 and continuing through 2024, this journal serves as a platform for the dissemination of significant research findings, theoretical advancements, and practical applications in the realm of mental health. With its ISSN 1509-2046 and E-ISSN 2083-828X, it stands out for its commitment to enhancing the understanding of psychiatric disorders and treatments. While it currently reflects a Q3 ranking in Clinical Psychology and a Q4 ranking in Psychiatry and Mental Health, its growing impact and visibility in academic circles are evident from its Scopus rankings, placing it within the 28th and 24th percentiles of its respective categories. The journal emphasizes open access, promoting equitable access to valuable knowledge for researchers, practitioners, and students alike, thus fostering collaboration and innovation in the field. As the mental health landscape evolves, the Archives of Psychiatry and Psychotherapy remains an essential resource for those dedicated to advancing psychiatric practice and research.

Klinik Psikiyatri Dergisi - Turkish Journal of Clinical Psychiatry is a distinguished open-access journal dedicated to the evolving field of psychiatry and mental health. Published by KLINIK PSIKIYATRI DERGISI in Turkey since 1998, this journal aims to provide a platform for the dissemination of research, clinical studies, and reviews that contribute to the understanding of psychological disorders and treatment methodologies. With an ISSN of 1302-0099 and an E-ISSN of 2146-7153, the journal is indexed in various databases, although it currently holds a rank of 460/567 in the Scopus ranking for the category of Medicine: Psychiatry and Mental Health. The journal operates under an open-access model, ensuring that research findings are readily accessible to a wide audience, contributing to greater knowledge and awareness in the field. As it converges from 2017 to 2024, Klinik Psikiyatri Dergisi continues to strive for excellence, providing valuable insights and resources for researchers, professionals, and students interested in the complexities of mental health.

JAMA Psychiatry, published by the American Medical Association, stands as a leading peer-reviewed journal in the fields of psychiatry and mental health, featuring an impressive impact factor that reflects its significance in advancing research and clinical practice. With an ISSN of 2168-622X and an E-ISSN of 2168-6238, this journal operates on a comprehensive access model that allows for the dissemination of vital research findings to a global audience. Since its inception in 2013, JAMA Psychiatry has consistently ranked in the top quartile (Q1) in both the Medicine (miscellaneous) and Psychiatry and Mental Health categories, with a remarkable Scopus rank of #4 out of 567, placing it in the 99th percentile. Addressed from its headquarters in Chicago, Illinois, the journal's objectives encompass the publication of original clinical research, innovative treatment strategies, and insightful reviews that enrich the understanding of psychiatric disorders. By bridging the gap between research and real-world application, JAMA Psychiatry remains an essential resource for researchers, clinicians, and students dedicated to improving mental health outcomes.